Anti-obesity medication tirzepatide remains effect
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an in
Source: newswise.com
Eli Lilly Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eli Lilly Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eli Lilly Inc Today - Breaking & Trending Today
Anti-obesity medication tirzepatide shown to remain effective even for those with diabetes and other complications
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.
Source: medicalxpress.com
THE SKIN OF COLOR SOCIETY (SOCS) REPORTS A BANNER YEAR OF PROGRESS TOWARD GREATER DIVERSITY & INCLUSION IN DERMATOLOGY AND HEALTH EQUITY FOR PATIENTS OF COLOR
/PRNewswire/ -- The Skin of Color Society (SOCS), the global leader in skin of color dermatology, reports that 2023 was a year of exceptional progress in...
Source: prnewswire.com
Neftlix, Alphabet rise; Lilly, Concentrix fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday: Alphabet Inc., up $4.97 to $98.02. Google's owner is cutting 12,000 jobs, about 6% of its workforce, the latest tech company to trim staff.
Source: apnews.com
Alzheimers Therapeutic Global Market Report 2022: Several Drugs in Pipeline Showing Promise in Fight Against Disease
/PRNewswire/ -- The "Alzheimers Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Source: prnewswire.com